Acadia Pharmaceuticals (0A4W.LSE) Q4 2023 Earnings

Nov 2Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.45
-0.3
-0.14
0.01

Details

Expected EPS
-0.45
Actual EPS
-0.4
Surprise EPS
0.05
Surprise Percent
+11.11%

Description

⁨Acadia Pharmaceuticals⁩ (⁦0A4W.LSE⁩) has reported earnings of ⁦-0.4⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts